Session Details
[Pj-009]Japanese Poster Session 009 Parkinson's disease (Pharmacotherapy 1)
Wed. May 21, 2025 5:20 PM - 6:40 PM JST
Wed. May 21, 2025 8:20 AM - 9:40 AM UTC
Wed. May 21, 2025 8:20 AM - 9:40 AM UTC
ポスター会場(大阪国際会議場3F イベントホール)
Chair: Noriko Nishikawa（Juntendo University School of Medicine, Japan）
[Pj-009-1]Tactile hallucinations in patients with Parkinson's disease
Yuka Komatsu, Hiroshi Kataoka, Hitoki Nanaura, Kazuma Sugie (Department of Neurology, Nara Medical University, Japan)
[Pj-009-2]Anti-Parknison therapy's recommendations for older Parkinson disease patients using Delphi method
Takashi Osada1, Mutsumi Iijima2, Masaki Takao1, Kanto Parkinson's Disease Study Group3 (1.National Center Hospital National Center of Neurology and Psychiatry Department of General Internal Medicine, Japan, 2.Department of Neurology, School of Medicine, Tokyo Women's Medical University, Japan, 3.Kanto Parkinson's Disease Study Group, Japan)
[Pj-009-3]Ultrasound and pathology findings of subcutaneous induration associated with Foslevodopa Foscarbidopa Hydratetreatment treatment
Shusuke Takahashi1, Kazuhiro Tomiyasu1, Norisuke Satori2, Kei Furui1, Yasuo Harigaya1, Toshio Fukuda3, Ban Mihara1 (1.Department of Neurology, Mihara Memorial Hospital, Japan, 2.Department of Rehabilitation, Mihara Memorial Hospital, Japan, 3.Department of Pathology, Mihara Memorial Hospital, Japan)
[Pj-009-4]Practicalities of continuous subcutaneous infusion treatment introduced at our hospital
Yumi Nakada1, Tomoaki Nada1, Masahiro Ishida1, Tomohito Kawano1, Yuki Taira1, Ken Ikegami1, Taijun Yunoki1, Mami Takemoto1, Yosuke Osakada1, Ryuta Morihara1, Toru Yamashita1, Kenya Nishioka2, Hiroyuki Ishiura1 (1.Department of Neurology, Okayama University, Japan, 2.Department of Neurology, Juntendo University School of Medicine, Japan)
[Pj-009-5]A Phase I Study of TR-012001, a Nasal Levodopa, in Healthy Adult Japanese Male Subjects
Ryota Ise1, Masaru Kaneko1, Shunji Haruta1, Yo Sonoda1, Yuki Akiyoshi1, Chizu Date1, Satoshi Nakano1, Takami Akagi1, Yasuhiro Sumiyoshi1, Shuichi Kanazashi1, Ichiro Nagata1, Hiroyuki Fukase2 (1.SNLD, Ltd., Japan, 2.Clinical Research Hospital Tokyo, Japan)
[Pj-009-6]Exploratory Phase II Study of TR-012001, a Nasal Levodopa
Masahiro Nomoto1, Hayato Yabe2, Rina Ando3, Yuji Hayashi4, Rie Asayama4, Sawa Aso4, Takemichi Tanaka4, Ayaka Tsuzuki4, Hiroyuki Yamada4, Naohito Hato4, Yasuhiro Sumiyoshi5, Takami Akagi5, Ryota Ise5, Yuki Akiyoshi5, Chizu Date5, Satoshi Nakano5, Ryosuke Suzuki5, Yo Sonoda5, Shunji Haruta5, Ichiro Nagata5 (1.Department of Neurology, Clinical Research Center, Saiseikai Imabari Hospital, Japan, 2.Department of Neurology, Saiseikai Matsuyama Hospital, Japan, 3.Department of Clinical Pharmacology and Therapeutics, Ehime University Graduate School of Medicine, Japan, 4.Department of Otolaryngology, Head and Neck Surgery, Ehime University Graduate School of Medicine, Japan, 5.SNLD, Ltd., Japan)